Endothelin-1 for the differential diagnosis between interstitial lung disease associated with autoimmune diseases and idiopathic pulmonary fibrosis
S. REMUZGO-MARTÍNEZ (Santander, Spain), B. Atienza-Mateo (Santander, Spain), V. Pulito-Cueto (Santander, Spain), F. Genre (Santander, Spain), V. Mora-Cuesta (Santander, Spain), D. Iturbe-Fernández (Santander, Spain), V. Portilla (Santander, Spain), O. Gualillo (Santiago de Compostela, Spain), A. Corrales (Santander, Spain), S. Castañeda (Madrid, Spain), R. López-Mejías (Santander, Spain), J. Cifrián (Santander, Spain), M. González-Gay (Johannesburg, South Africa)
Source: International Congress 2022 – New mechanistic insights into acute and chronic interstitial lung disorders
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. REMUZGO-MARTÍNEZ (Santander, Spain), B. Atienza-Mateo (Santander, Spain), V. Pulito-Cueto (Santander, Spain), F. Genre (Santander, Spain), V. Mora-Cuesta (Santander, Spain), D. Iturbe-Fernández (Santander, Spain), V. Portilla (Santander, Spain), O. Gualillo (Santiago de Compostela, Spain), A. Corrales (Santander, Spain), S. Castañeda (Madrid, Spain), R. López-Mejías (Santander, Spain), J. Cifrián (Santander, Spain), M. González-Gay (Johannesburg, South Africa). Endothelin-1 for the differential diagnosis between interstitial lung disease associated with autoimmune diseases and idiopathic pulmonary fibrosis. 2795
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|